Search

The US Food and Drug Administration (FDA) has approved the drug larotrectinib for cancers caused by a genetic mutation called a TRK fusion. Today’s decision marks a transformation in the field of precision medicine as this is the first time that an entirely new treatment has received a tumor-agnostic indication at its initial approval, meaning that the drug was approved based on mutation type rather than on where in the body the tumor originated.

… Monday, November 26, 2018 Bottom Line VIDEO | 02:42 Rihanna's Story of Treatment on a Clinical Trial with Larotrectinib Meet Rihanna, who was on a clinical trial with larotrectinib. Video Details The US Food and Drug Administration (FDA) has approved the drug larotrectinib for cancers caused by a genetic

MSK played a central role in the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC)’s landmark decision in April 2024 to accept measurable residual disease (MRD) as an intermediate clinical endpoint for accelerated approval of new drugs and new indications in multiple myeloma clinical trials.

… Thursday, August 8, 2024 A Q&A with MSK Experts  MSK played a central role in the U.S. Food and Drug Administration (FDA)  Oncologic Drugs Advisory Committee (ODAC)’s landmark decision in April 2024 to accept measurable residual disease (MRD) as an intermediate clinical endpoint for accelerated approval

Meet Lisa DeAngelis, MSK's new Physician-in-Chief. She discusses her upbringing, her early career at MSK, and her top priorities as physician-in-chief.

… Thursday, January 2, 2020 Summary Lisa DeAngelis, the new Physician-in-Chief, has deep roots at MSK. After more than 30 years at Memorial Sloan Kettering, Lisa DeAngelis still gets up at 6 a.m. , goes to the gym if she’s feeling ambitious, and walks to and from work with her husband, Peter Okin, a cardiology

Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center (MSK) is essential to advancing our mission.

… Friday, April 1, 2022 Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center (MSK) is essential to advancing our mission. Read more to learn about your impact. Fundraising Events at MSK Cycle for Survival’s 2022 Season and 2021 Allocations Cycle for Survival

MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Kravis WISE fellowship grant recipients.

… Tuesday, March 11, 2025 MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Kravis WISE fellowship grant recipients. This year’s winners are postdoctoral fellows  Almudena Chaves-Pérez, PhD , and Adriana Mujal, PhD , and graduate students  Hina Shah and

Memorial Sloan Kettering Cancer Center is leading an innovative initiative to reduce cancer and cardiovascular health disparities in South Asian immigrant communities in the United States.

… Thursday, September 19, 2013 Memorial Sloan Kettering Cancer Center is leading an innovative initiative to reduce cancer and cardiovascular health disparities in South Asian immigrant communities in the United States. The effort, called South Asian Health: From Research to Practice and Policy , is the

The day before Thanksgiving, Mary Oehrlein got the earth-shattering news. She’d had some tests at her local hospital to see what was causing her stomach problems. When she got a message to check her patient portal for results, she was stunned to read the words “possible pancreatic cancer.” She went to tell Rich, her husband of 53 years, and they cried.

… Thursday, February 2, 2023 The day before Thanksgiving, Mary Oehrlein got the earth-shattering news. She’d had some tests at her local hospital to see what was causing her stomach problems. When she got a message to check her patient portal for results, she was stunned to read the words “possible pancreatic

El día antes de Acción de Gracias, Mary Oehrlein recibió la noticia demoledora. Se había hecho algunas pruebas en un hospital local para averiguar la causa de sus problemas estomacales. Cuando recibió un mensaje para consultar los resultados en su portal para pacientes, se quedó atónita al leer las palabras “posible cáncer de páncreas”. Fue a contárselo a su esposo Rich, con el que lleva casada 53 años, y lloraron juntos.

… Thursday, February 2, 2023 El día antes de Acción de Gracias, Mary Oehrlein recibió la noticia demoledora. Se había hecho algunas pruebas en un hospital local para averiguar la causa de sus problemas estomacales. Cuando recibió un mensaje para consultar los resultados en su portal para pacientes, se

Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.

… Tuesday, November 14, 2023 Investigator Ming Li, PhD , has dedicated his career to understanding the intricate workings of the immune system — both in general and for the critical role it plays in cancer. Study by study, his lab at Memorial Sloan Kettering Cancer Center (MSK) is sharing new insights

Learn about the Mediterranean diet and how it could be beneficial for cancer survivors. Always check with your care team before making any changes to your diet.

… Wednesday, February 2, 2022 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how